Mechanisms, clinical translation, and future perspectives of liver-mediated immunoprotection in combined organ transplantation
World Journal of Gastrointestinal Surgery · 2026-11-27 · 18 (11)
DOI: 10.4240/wjgs.124378 ↗Abstract
Owing to its unique tolerogenic immune microenvironment, the liver can confer substantial immunologic protection on concurrently transplanted allogeneic grafts in combined organ transplantation. This review summarizes the molecular and cellular mechanisms underlying liver-mediated immunoprotection, including antigen presentation by liver sinusoidal endothelial cells and tolerogenic dendritic cells, enrichment of regulatory T cells, clonal deletion of donor-reactive T cells, clearance of donor-specific antibodies, and the establishment of microchimerism. We further synthesize clinical outcome data from combined liver-intestinal transplantation and multivisceral transplantation, and evaluate the translational potential of optimized immunosuppressive strategies, cell-based therapies, and emerging technologies such as normothermic machine perfusion. Although current evidence supports the immunoprotective role of the liver, its precise molecular mechanisms remain incompletely defined and require further validation. Prospective multicenter studies are also warranted.
EUVIMED